Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1426-1431

  Frothingha, Richard ^a,b   Meeker O'Connell, Winifred A ^b   Talbot, Elizabeth A S ^b   George, James W ^b   Kreuzer, Kenneth N ^b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; NICOTINAMIDASE; NICOTINAMIDE; PYRAZINAMIDE;

ARTICLE; BACTERIAL GENE; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPOSON;

EID: 0029890520     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1426     Document Type: Article

References (40)

1. Altamirano, M., J. Marostenmaki, A. Wong, M. Fitz Gerald, W. A. Black, and J. A. Smith. 1994. Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. J. Infect Dis. 169:1162-1165.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol Biol. 215:403-410
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl, L. M. Albright, D. M. Coen, A. Varki, and K. Janssen (ed.). 1995 Current protocols in molecular biology. John Wiley & Sons, Inc., Brooklyn, N.Y.
4. Bachmann, B. J. 1990. Linkage map of Escherichia coli K-12, edition 8. Microbiol. Rev. 54:130-197.
5. Bachmann, B. J., K. B. Low, and A. L. Taylor. 1976. Recalibrated linkage map of Escherichia coli K-12. Bacteriol. Rev. 40:116-167.
6. Bartolome, B., Y. Jubete, E. Martinez, and F. de la Cruz. 1991 Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives. Gene 102:75-78
7. Cambau, E., W. Sougakoff, M. Besson, C. Truffot-Pernot, J. Grosset, and V. Jarlier. 1994 Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. J. Infect. Dis. 170:479-483.
8. Cambau, E., W. Sougakoff, and V. Jarlier. 1994. Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria. FEMS Microbiol. Lett. 116:49-54.
9. Centers for Disease Control and Prevention. 1993 Initial therapy for tuberculosis in the era of multidrug resistance Recommendations of the advisory council for the elimination of tuberculosis. Morbid. Mortal Weekly Rep. 42(RR-7): 1-8.
10. Dickinson, E. S., and T. K. Sundaram. 1970. Chromosomal location of a gene defining nicotinamide deamidase in Eschenchia coli J. Bacteriol 101: 1090-1091.
11. Edlin, B. R., J. I. Tokars, M. H. Grieco, J. T. Crawford, J. Williams, E. M. Sordillo, K. R. Ong, J. O. Kilburn, S. W. Dooley, K. G. Castro, W. R. Jarvis, and S. D. Holmberg. 1992. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 326:1514-1521.
12. Frothingham, R., H. G. Hills, and K. H. Wilson. 1994. Extensive DNA sequence conservation throughout the Mvcobacterium tuberculosis complex. J Clin Microbiol 32:1639-1643.
13. Frothingham, R., and K. H. Wilson. 1993. Sequence-based differentiation of strains in the Mycobacterium avium complex. J. Bacteriol. 175:2818-2825.
14. Gottesman, M. M., M. L. Hicks, and M. Gellert. 1973 Genetics and function of DNA ligase in Escherichia coli. J Mol. Biol. 77:531-547.
15. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids J. Mol. Biol 166:557-580.
16. Heifets, L. B., M. D. Iseman, A. J. Crowle, and P. J. Lindholm-Levy. 1986. Pyrazinamide is not active in vitro against Mycobacterium avium complex. Am. Rev. Respir. Dis 134:1287-1288.
17. Huebner, R. E., R. C. Good, and J. I. Tokars. 1993. Current practices in mycobacteriology: results of a survey of state public health laboratories. J. Clin. Microbiol. 31:771-775.
18. Iseman, M. D. 1993. Treatment of multidrug-resistant tuberculosis. N Engl. J. Med. 329:784-791.
19. Jerlström, P. G., D. A. Bezjak, M. P. Jennings, and I. R. Beacham. 1989 Structure and expression in Escherichia coli K-12 of the L-asparaginase I-encoding ansA gene and its flanking regions. Gene 78:37-46.
20. Kleckner, N., J. Render, and S. Gottesman. 1991. Uses of transposons with emphasis on Tn10. Methods Enzymol. 204:139-180.
21. Konno, K., F. M. Feldmann, and W. McDermott. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli Am. Rev. Respir Dis. 95:461-469.
22. Lotte, A., O. Wasz-Hockert, and N. Poisson. 1988. Second IUATLD study on complications induced by intradermal BCG-vaccination Bull. Int. Union Tuberc. 63:47-59.
23. Lotte, A., O. Wasz-Hockert, N. Poisson, N. Dumitrescu, M. Verron, and E. Couvet. 1984 BCG complications: estimates for the risks among vaccinated subjects and statistical analysis of their main characteristics Adv. Tuberc. Res. 21:107-193.
24. Mackay, A., M. J. Alcorn, I. M. Macleod, B. H. R. Stack, T. Macleod, M. Laidlaw, J. S. Millar, and R. G. White. 1980. Fatal disseminated BCG infection in an 18-year-old boy Lancet ii:1332-1334.
25. Miller, M. A., L. Thibert, F. Desjardins, S. H. Siddiqi, and A. Dascal. 1995. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay. J. Clin. Microbiol. 33:2468-2470.
26. National Institutes of Health. 1980. Mycobacterial culture collection. NIH publication no. 80-289 National Institutes of Health, Bethesda, Md
27. Pardee, A. B., E. J. Benz, Jr., D. A. St. Peter, J. N. Drieger, M. Meuth, and H. W. Trieshmann, Jr. 1971. Hyperproduction and purification of nicotinamide deamidase, a microconstitutive enzyme of Escherichia coli J Biol. Chem. 246:6792-6796.
28. Romao, M. J., D. Turk, F.-X. Gomis-Ruth, R. Huber, G. Schumacher, H. Möllering, and L. Russmann. 1992. Crystal structure analysis, refinement and enzymatic reaction mechanism of N-carbamoylsarcosine amidohydrolase from Arthrobacter sp. at 2.0 Å resolution. J. Mol Biol. 226:1111-1130.
29. Ŝićević, S. 1972. Generalized BCG tuberculosis with fatal course in two sisters Acta Paediatr Scand. 61:178-184.
30. Steele, M. A., and R. M. Des Prez. 1988. The role of pyrazinamide in tuberculosis chemotherapy. Chest 94:842-844.
31. Stoeckle, M. Y., L. Guan, N. Riegler, I. Weitzman, B. Kreiswirth, J. Kornblum, F. Laraque, and L. W. Riley. 1993. Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J. Infect. Dis. 168:1063-1065.
32. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, Jr., and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature (London) 351:456-460.
33. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650
34. Telenti, A., P. Imboden, F. Marchesi, T. Schmidheini, and T. Bodmer. 1993. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother 37:2054-2058.
35. Tritz, G. J. 1987. NAD biosynthesis and recycling, p. 557-563. In F. C. Neidhardt, J L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typlumurium: cellular and molecular biology. American Society for Microbiology, Washington, D.C.
36. Turett, G. S., E. E. Telzak, L. V. Torian, S. Blum, D. Alland, I. Weisfuse, and B. A. Fazal. 1995. Improved outcomes for patients with multidrug-resistant tuberculosis Clin. Infect. Dis. 21:1238-1244.
37. Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
38. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampin resistance in pathogenic mycobacteria Antimicrob. Agents Chemother. 38:2380-2386.
39. Zhang, Y., T. Garbe, and D. Young. 1993. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8:521-524.
40. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992 The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (London) 358:591-593.